SmallCap
CompaniesStatistics

(주)이노보테라퓨틱스

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)이노보테라퓨틱스
Business Reg. No.3798601520
CEO박희동
Address서울 마포구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products의약품의 개발,의약품 생산/소프트웨어 개발,판매
EstablishedContact
Phone02-6956-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
-
ROE
-1.81%
Debt Ratio
-111%

Certification Status


Venture Certified

Cert. History
벤처투자유형2020-09-24 ~ 2022-09-23202003010822020-09-24
벤처투자유형2022-09-24 ~ 2025-09-23202209150100012020-09-24
벤처투자유형2025-09-24 ~ 2028-09-23202509100100122020-09-24

Financial Statements


3-Year Financial Data
Item202420232022
Revenue

0.0B

0.0B

0.0B

Operating Profit

-130B

-116B

-99B

Net Profit

8.9B

-169B

-211B

Total Assets

54B

151B

247B

Total Liabilities

549B

678B

617B

Total Equity

-495B

-527B

-370B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
0

- 0.0%

vs. 3-Year Avg.: 0
Operating Profit
-130B

20.6%

vs. 3-Year Avg.: -108B
Debt Ratio
-111.0%

24.8%

vs. 3-Year Avg.: -147.7%
ROE
-1.8%

104.1%

vs. 3-Year Avg.: 44.5%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
박희동대표이사대표

Employment Status


Regular EmployeesContact
CEO박희동

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울 마포구",
  "ceo_name": "박희동",
  "certificate": [
    {
      "cert_number": "20200301082",
      "changes": "",
      "disclosure_date": "2020-09-24",
      "first_cert_date": "2020-09-24",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2020-09-24 ~ 2022-09-23"
    },
    {
      "cert_number": "20220915010001",
      "changes": "",
      "disclosure_date": "2022-09-15",
      "first_cert_date": "2020-09-24",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-09-24 ~ 2025-09-23"
    },
    {
      "cert_number": "20250910010012",
      "changes": "",
      "disclosure_date": "2025-09-10",
      "first_cert_date": "2020-09-24",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-09-24 ~ 2028-09-23"
    }
  ],
  "company_name": "(주)이노보테라퓨틱스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 520000000,
      "cost_of_sales": 0,
      "current_assets": 22247931000,
      "current_liabilities": 60651331000,
      "gross_profit": 0,
      "net_income": -21051641000,
      "net_income_bs": -21051640000,
      "non_current_assets": 2462488000,
      "non_current_liabilities": 1052490000,
      "non_operating_expenses": 11619208000,
      "non_operating_income": 483787000,
      "operating_profit": -9916220000,
      "revenue": 0,
      "sga_expenses": 9916220000,
      "total_assets": 24710419000,
      "total_equity": -36993402000,
      "total_liabilities": 61703821000
    },
    "2023": {
      "capital_stock": 5200000000,
      "cost_of_sales": 0,
      "current_assets": 12289540000,
      "current_liabilities": 66930228000,
      "gross_profit": 0,
      "net_income": -16936442000,
      "net_income_bs": -16936442000,
      "non_current_assets": 2768081000,
      "non_current_liabilities": 856267000,
      "non_operating_expenses": 5798323000,
      "non_operating_income": 464517000,
      "operating_profit": -11602636000,
      "revenue": 0,
      "sga_expenses": 11602636000,
      "total_assets": 15057622000,
      "total_equity": -52728873000,
      "total_liabilities": 67786495000
    },
    "2024": {
      "capital_stock": 5355000000,
      "cost_of_sales": 0,
      "current_assets": 2609943000,
      "current_liabilities": 53716445000,
      "gross_profit": 0,
      "net_income": 894268000,
      "net_income_bs": 894268000,
      "non_current_assets": 2827619000,
      "non_current_liabilities": 1175269000,
      "non_operating_expenses": 3555934000,
      "non_operating_income": 17422370000,
      "operating_profit": -12972168000,
      "revenue": 0,
      "sga_expenses": 12972168000,
      "total_assets": 5437562000,
      "total_equity": -49454151000,
      "total_liabilities": 54891713000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "5,000,001,100",
      "changes": "5,000,001,100",
      "date": "2025-03-21"
    },
    {
      "amount": "2,001,000,000",
      "changes": "2,001,000,000",
      "date": "2022-01-26"
    },
    {
      "amount": "4,000,000,000",
      "changes": "4,000,000,000",
      "date": "2022-01-26"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2022-01-26"
    },
    {
      "amount": "2,490,000,000",
      "changes": "2,490,000,000",
      "date": "2021-12-30"
    },
    {
      "amount": "2,020,000,000",
      "changes": "2,020,000,000",
      "date": "2021-12-21"
    },
    {
      "amount": "5,001,000,000",
      "changes": "5,001,000,000",
      "date": "2021-11-30"
    },
    {
      "amount": "5,001,499,000",
      "changes": "5,001,499,000",
      "date": "2021-11-30"
    },
    {
      "amount": "2,001,000,000",
      "changes": "2,001,000,000",
      "date": "2020-02-18"
    },
    {
      "amount": "2,000,027,000",
      "changes": "2,000,027,000",
      "date": "2020-02-18"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2020-01-07"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2020-01-07"
    },
    {
      "amount": "5,000,066,250",
      "changes": "5,000,066,250",
      "date": "2019-12-27"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-12-27"
    }
  ],
  "main_products": "의약품의 개발,의약품 생산/소프트웨어 개발,판매",
  "phone": "02-6956-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsNot Collected
Not Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Venture System Detail2026-02-25
Collected